Leaflet: information for the user
Lomexin 200 mg vaginal soft capsules
Fenticonazole nitrate
Read this leaflet carefully before you start using this medicine, because it contains important information for you.
1. What Lomexin 200 mg vaginal soft capsules are and what they are used for
2. What you need to know before you start using Lomexin 200 mg vaginal soft capsules
3. How to use Lomexin 200 mg vaginal soft capsules
4. Possible side effects
5. Storage of Lomexin 200 mg vaginal soft capsules
6. Contents of the pack and additional information
Lomexin 200 mg vaginal soft capsules belongs to a group of medicines called gynecological antifungals and antiseptics.
Lomexin 200 mg vaginal soft capsules is indicated for the treatment of vulvovaginal candidiasis.
Do not use Lomexin 200 mg vaginal soft capsules:
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to use Lomexin 200 mg vaginal soft capsules:
Children and adolescents
Lomexin is not recommended for girls under 16 years old.
Other medications and Lomexin 200 mg vaginal soft capsules
The oils and fatty excipients in the composition of the vaginal soft capsules may damage barrier contraceptives made of latex, such as condoms and diaphragms (see section “Warnings and precautions”).
It is not recommended to use spermicides (substances inserted vaginally, which destroy sperm and are used as a contraceptive method alone or in combination with, for example, diaphragms). These may inactivate the vaginal treatment.
Pregnancy, lactation, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, or if you intend to become pregnant, consult your doctor before using this medication.
The use of Lomexin should be under medical supervision during pregnancy and lactation.
Driving and operating machines
The influence of Lomexin 200 mg vaginal soft capsules on the ability to drive and operate machines is negligible or insignificant.
Lomexin 200 mg vaginal soft capsules contain Parahydroxybenzoate of ethyl, sodium salt (E 215) and Parahydroxybenzoate of propyl, sodium salt (E 217)
It may cause allergic reactions (possibly delayed) because it contains Parahydroxybenzoate of ethyl, sodium salt (E 215) and Parahydroxybenzoate of propyl, sodium salt (E 217).
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Lomexin vaginal capsules are for vaginal use only. Do not ingest.
The vaginal capsule should be inserted as deeply as possible while lying down.
The recommended dose is:
Use in children and adolescents
The recommended dose for children 16 years of age and older is the same as for adults.
If you use moreLomexin 200 mg vaginal soft capsulesthan you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service. Phone: 91 562 04 20, indicating the medication and the amount used or ingested by mistake.
If you forgot to useLomexin 200 mg vaginal soft capsules
Do not use a double dose to compensate for the missed doses.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medications, this medication may produce adverse effects, although not all people experience them.
You may experience a mild sensation of burning when the medication is introduced into the vagina, which disappears quickly. When used as recommended, the absorption of Lomexin is insignificant and no adverse effects have been reported in the rest of the body (systemic effects).
The use of topical medications, especially if prolonged, may cause sensitization (see section “Warnings and Precautions”).
The following adverse effects have been reported with Lomexin:
Very Rare (affects less than 1 patient in 10,000)
Unknown Frequency:
Hypersensitivity at the application site.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through theSpanish System for Pharmacovigilance of Medicinal Products for Human Use:www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
No requires special conditions for conservation.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition ofLomexin 200 mg vaginal soft capsules
Core excipients: medium-chain triglycerides, colloidal silica.
Capsule excipients: gelatin, glycerol (E 422), titanium dioxide (E 171), ethyl parahydroxybenzoate, sodium salt (E 215), propyl parahydroxybenzoate, sodium salt (E 217).
Product appearance and packaging contents
Lomexin 200 mg, is presented in the form of white-beige vaginal soft capsules, in PVC/Aluminum blisters, in containers containing 3 vaginal soft capsules.
Marketing authorization holder and manufacturer responsible
Marketing authorization holder
Casen Recordati, S.L.,
Autovía de Logroño, km 13.300
50180 UTEBO. Zaragoza (Spain)
Manufacturer responsible
CATALENT ITALY, S.P.A.
Via Nettunense, Km 20,100
04011 Aprilia (LT)
Italy
Last review date of this leaflet: September 2020
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.